Hepatitis B Vaccines Manufacturing Facility at GSK Tuas

An exclusive glimpse into our Tuas vaccines manufacturing facilityПодробнее

GSK to build new manufacturing facility in Singapore for Hepatitis B vaccinesПодробнее

What is GMMA vaccine technology?Подробнее

How vaccines workПодробнее

Sanofi invests S$638m in vaccine production facility in SingaporeПодробнее

GSK Vaccines - Technology and talent driven vaccines production accelerationПодробнее

GSK Experiences: Vaccines Manufacturing Future Leaders ProgrammeПодробнее

新加坡投资动态：葛兰素史克投入3.43亿新元扩建新加坡大士疫苗制造厂Подробнее

Hepatitis B Everything You Need to Know | #MCAShortsПодробнее

Turning Vaccines into VaccinationПодробнее

Hepatitis B vaccinations animationПодробнее

Ahead Together: Breakthrough vaccine innovationПодробнее

Why get your Hep B vaccine?Подробнее

Hepatitis B Travel VaccinationПодробнее

Expanding Access to Hepatitis B VaccinationПодробнее

GSK Plans Phase III Clinical Trial for Hepatitis B | bepirovirsen Clinical Trial Phase 3Подробнее

Vaccine of the Day - Hepatitis B - What, When and WhyПодробнее

Making a therapeutic Hepatitis B vaccine possibleПодробнее

Hepatitis B Testing and Vaccination Programs in Correctional FacilitiesПодробнее